Table 2.
N-terminal domain interactions with Ure2p
Plasmid | URE2 part | GFP signal* | Curing,† USA−/total | Interference,‡ USA+/106 |
---|---|---|---|---|
pH199 | –GFP | + cytopl. | 15/718 | 13 |
pVTG4 | M1, M2–R65–GFP | + | 439/440 | 68,000 |
pH545 | M1, N3–R65–GFP | + | 200/200 | 93,000 |
pH486 | M1, N4–R65–GFP | + | 100/100 | 73,000 |
pH762 | M1, N5–R65–GFP | + | 100/100 | 22,000 |
pH487 | M1, G6–R65–GFP | + | 9/300 | 11,000 |
pH408 | M1, N7–R65–GFP | + | 229/340 | 109,000 |
pH763 | M1, V9–R65–GFP | + | 197/200 | 35,000 |
pH764 | M1, N11–R65–GFP | + | 6/180 | 79,000 |
pH349 | M1, S13–R65–GFP | + | 0/118 | 71 |
pH350 | M1, R24–R65–GFP | + cytopl. | 1/118 | 3 |
pH351 | M1, S34–R65–GFP | + | 0/118 | 8 |
pH352 | M1, N45–R65–GFP | + cytopl. | 0/118 | 3 |
pH769 | M1–S33, S63–R65–GFP | + cytopl. | 5/100 | 4 |
pH768 | M1–I35, S63–R65–GFP | + cytopl. | 4/100 | 1 |
pH767 | M1–F37, S63–R65–GFP | + mainly cytopl. | 4/100 | 4,600 |
pH442 | M1–F39, S63–R65–GFP | + | 0/240 | 130,000 |
pH484 | M1–V43, S63–R65–GFP | − | 0/200 | 66 |
pH548 | M1–N44, S63–R65–GFP | + | 129/300 | 60,000 |
pH547 | M1–N45, S63–R65–GFP | + | 101/200 | 57,000 |
pH546 | M1–N46, S63–R65–GFP | + | 80/200 | 61,000 |
pH485 | M1–N47, S63–R65–GFP | + | 295/300 | 39,000 |
pH766 | M1–N49, S63–R65–GFP | + | 86/100 | 70,000 |
pH441 | M1–N50, S63–R65–GFP | + | 139/140 | 63,000 |
pH765 | M1–S53, S63–R65–GFP | + | 95/100 | 53,000 |
The GFP signal of most fusion constructs transformed into the [URE3] strain was aggregated. Others showed an even cytoplasmic distribution (‘cytopl.’).
Curing was tested as in Table 1.
Interference was measured as USA+ cells per 106 cells. All USA+ clones tested became USA− on loss of the plasmid, indicating that this is not [URE3] induction, but simply interference with Ure2p action.